Is AltRx a Scam or is it Legitimate?

Key Red Flags and Issues

• FDA Warning Letter: The U.S. Food and Drug Administration (FDA) issued an official warning letter to AltRx in June 2026 for marketing unapproved and misbranded compounded semaglutide and tirzepatide drugs with false manufacturer labeling.
• Billing and Unauthorized Charges: Some customers report unexpected price hikes, hidden recurring fees, double-billing, and large unauthorized withdrawals on credit card statements.
• Bait-and-Switch Tactics: Users frequently state they were lured in by low introductory pricing (such as $89 or $129 per month), only to face much higher recurring charges or unexpected substitutions to different medication compounds.
• Poor Customer Service & Unresponsive Refunds: Customers report blocked numbers, unreturned emails, wiped portal histories, and refusal of refunds for delayed, damaged, or unreceived shipments.
• Low Ratings: AltRx holds an F rating and a 1.06 out of 5-star customer review average on the Better Business Bureau (BBB) with nearly 200 formal complaints.

Read the FDA Warning Letter for official details on their regulatory violations, or check the Better Business Bureau AltRx Profile to view consumer complaints and reviews.